XML 36 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity The following table summarizes the Company’s stock option activity for the three months ended March 31, 2025:

 

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price per
share

 

 

Weighted-
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Balance at December 31, 2024

 

 

4,189,746

 

 

$

10.02

 

 

 

9.19

 

 

$

34,324

 

Granted

 

 

1,629,880

 

 

 

16.55

 

 

 

 

 

 

 

Exercised

 

 

(3,240

)

 

 

1.80

 

 

 

 

 

 

 

Forfeited

 

 

(190,364

)

 

 

12.40

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding at March 31, 2025

 

 

5,626,022

 

 

$

11.83

 

 

 

9.16

 

 

$

12,185,298

 

Options vested and exercisable at March 31, 2025

 

 

914,448

 

 

 

5.43

 

 

 

8.48

 

 

 

4,646,260

 

Options vested and expected to vest at March 31, 2025

 

 

5,626,022

 

 

$

11.83

 

 

 

9.16

 

 

$

12,185,298

 

Summary of Restricted Stock Awards Grant Activity

The following table summarizes the Company’s service-based RSA grant activity for the three months ended March 31, 2025:

 

 

RSAs

 

 

Weighted-
Average Grant
Date Fair Value

 

Unvested shares at December 31, 2024

 

 

976,596

 

 

 

3.69

 

Granted

 

 

 

 

 

 

Vested

 

 

(135,164

)

 

 

3.53

 

Forfeited

 

 

(44,792

)

 

 

2.92

 

Unvested shares at March 31, 2025

 

 

796,640

 

 

$

3.77

 

Summary of Performance-based RSA Grant Activity

The following table summarizes the Company’s performance-based RSA grant activity for the three months ended March 31, 2025:

 

 

RSAs

 

 

Weighted-
Average Grant
Date Fair Value

 

Unvested shares at December 31, 2024

 

 

444,235

 

 

$

3.63

 

Granted

 

 

 

 

 

 

Vested

 

 

(53,130

)

 

 

3.61

 

Forfeited

 

 

(41,216

)

 

 

2.92

 

Unvested shares at March 31, 2025

 

 

349,889

 

 

$

3.72

 

Summary of Share-based Compensation Expense The following table below summarizes the classification of the Company’s stock-based compensation expense related to stock options and restricted common stock awards in the condensed consolidated statements of operations and comprehensive loss (in thousands):

 

 

For the Three Months
Ended March 31,

 

 

2025

 

 

2024

 

General and Administrative

 

$

2,719

 

 

$

769

 

Research and Development

 

 

1,321

 

 

 

722

 

 

$

4,040

 

 

$

1,491